172 related articles for article (PubMed ID: 28164543)
1. Detection the Frequency and Characteristics of FLT3 Internal Tandem Duplication Mutations by Capillary Electrophoresis Assay and Next-Generation Sequencing in.
Ma L; Cao Y; Jiang Y; Cong X; Lu S; Shen J; Liu Q; Han C; Zhan Y; Cao Y
Clin Lab; 2016 Oct; 62(10):2065-2072. PubMed ID: 28164543
[TBL] [Abstract][Full Text] [Related]
2. [Application of High-throughput Sequencing in Acute Myeloid Leukemia Patients with Positive FLT3-ITD].
Ma L; Jiang YW; Wang ST; Liu Q; Cong X; Shen J; Cao YY; Cao YT
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):381-7. PubMed ID: 27150996
[TBL] [Abstract][Full Text] [Related]
3. Detection of FLT3 internal tandem duplication in targeted, short-read-length, next-generation sequencing data.
Spencer DH; Abel HJ; Lockwood CM; Payton JE; Szankasi P; Kelley TW; Kulkarni S; Pfeifer JD; Duncavage EJ
J Mol Diagn; 2013 Jan; 15(1):81-93. PubMed ID: 23159595
[TBL] [Abstract][Full Text] [Related]
4. Classes of ITD Predict Outcomes in AML Patients Treated with FLT3 Inhibitors.
Schwartz GW; Manning B; Zhou Y; Velu P; Bigdeli A; Astles R; Lehman AW; Morrissette JJD; Perl AE; Li M; Carroll M; Faryabi RB
Clin Cancer Res; 2019 Jan; 25(2):573-583. PubMed ID: 30181385
[TBL] [Abstract][Full Text] [Related]
5. Internal tandem duplication mutations in the tyrosine kinase domain of FLT3 display a higher oncogenic potential than the activation loop D835Y mutation.
Marhäll A; Heidel F; Fischer T; Rönnstrand L
Ann Hematol; 2018 May; 97(5):773-780. PubMed ID: 29372308
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of different FLT3-ITD mutations in acute myeloid leukemia.
Blau O; Berenstein R; Sindram A; Blau IW
Leuk Lymphoma; 2013 Jan; 54(1):145-52. PubMed ID: 22721497
[TBL] [Abstract][Full Text] [Related]
7. Accurate Detection and Quantification of FLT3 Internal Tandem Duplications in Clinical Hybrid Capture Next-Generation Sequencing Data.
Tung JK; Suarez CJ; Chiang T; Zehnder JL; Stehr H
J Mol Diagn; 2021 Oct; 23(10):1404-1413. PubMed ID: 34363960
[TBL] [Abstract][Full Text] [Related]
8. Targeted Informatics for Optimal Detection, Characterization, and Quantification of FLT3 Internal Tandem Duplications Across Multiple Next-Generation Sequencing Platforms.
Tsai HK; Brackett DG; Szeto D; Frazier R; MacLeay A; Davineni P; Manning DK; Garcia E; Lindeman NI; Le LP; Lennerz JK; Gibson CJ; Lindsley RC; Kim AS; Nardi V
J Mol Diagn; 2020 Sep; 22(9):1162-1178. PubMed ID: 32603763
[TBL] [Abstract][Full Text] [Related]
9. Characterisation and Clinical Significance of FLT3-ITD and non-ITD in Acute Myeloid Leukaemia Patients in Kelantan, Northeast Peninsular Malaysia.
Yunus NM; Johan MF; Ali Nagi Al-Jamal H; Husin A; Hussein AR; Hassan R
Asian Pac J Cancer Prev; 2015; 16(12):4869-72. PubMed ID: 26163606
[TBL] [Abstract][Full Text] [Related]
10. A DNA pool of FLT3-ITD positive DNA samples can be used efficiently for analytical evaluation of NGS-based FLT3-ITD quantitation - Testing several different ITD sequences and rates, simultaneously.
Mezei ZA; Tornai D; Földesi R; Madar L; Sümegi A; Papp M; Antal-Szalmás P
J Biotechnol; 2019 Sep; 303():25-29. PubMed ID: 31302157
[TBL] [Abstract][Full Text] [Related]
11. Frequency of FLT3 Internal Tandem Duplications in Adult Syrian Patients with Acute Myeloid Leukemia and Normal Karyotype.
Al-Arbeed IF; Wafa A; Moassass F; Al-Halabi B; Al-Achkar W; Abou-Khamis I
Asian Pac J Cancer Prev; 2021 Oct; 22(10):3245-3251. PubMed ID: 34711001
[TBL] [Abstract][Full Text] [Related]
12. Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples.
Cloos J; Goemans BF; Hess CJ; van Oostveen JW; Waisfisz Q; Corthals S; de Lange D; Boeckx N; Hählen K; Reinhardt D; Creutzig U; Schuurhuis GJ; Zwaan ChM; Kaspers GJ
Leukemia; 2006 Jul; 20(7):1217-20. PubMed ID: 16642044
[TBL] [Abstract][Full Text] [Related]
13. [Correlation of FLT3 gene expression level and internal tandem duplication mutation in acute myeloid leukemia and its clinical significance].
Wang YG; Liu XH; Liang Y; Jin J
Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):741-5. PubMed ID: 19176010
[TBL] [Abstract][Full Text] [Related]
14. [Prevalence and clinical significance of FLT3 internal tandem duplication mutation in acute leukemia].
Wang LH; Zhou CL; Zhang XW; Chen S; Wang M; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):393-6. PubMed ID: 15355689
[TBL] [Abstract][Full Text] [Related]
15. Insertion of FLT3 internal tandem duplication in the tyrosine kinase domain-1 is associated with resistance to chemotherapy and inferior outcome.
Kayser S; Schlenk RF; Londono MC; Breitenbuecher F; Wittke K; Du J; Groner S; Späth D; Krauter J; Ganser A; Döhner H; Fischer T; Döhner K;
Blood; 2009 Sep; 114(12):2386-92. PubMed ID: 19602710
[TBL] [Abstract][Full Text] [Related]
16. Hybridization capture-based next generation sequencing reliably detects FLT3 mutations and classifies FLT3-internal tandem duplication allelic ratio in acute myeloid leukemia: a comparative study to standard fragment analysis.
He R; Devine DJ; Tu ZJ; Mai M; Chen D; Nguyen PL; Oliveira JL; Hoyer JD; Reichard KK; Ollila PL; Al-Kali A; Tefferi A; Begna KH; Patnaik MM; Alkhateeb H; Viswanatha DS
Mod Pathol; 2020 Mar; 33(3):334-343. PubMed ID: 31471587
[TBL] [Abstract][Full Text] [Related]
17. The prognosis predictive value of FMS-like tyrosine kinase 3-internal tandem duplications mutant allelic ratio (FLT3-ITD MR) in patients with acute myeloid leukemia detected by GeneScan.
Lyu M; Liao H; Shuai X; Jin Y; Su J; Zheng Q
Gene; 2020 Feb; 726():144195. PubMed ID: 31669649
[TBL] [Abstract][Full Text] [Related]
18. A next-generation sequencing-based assay for minimal residual disease assessment in AML patients with
Levis MJ; Perl AE; Altman JK; Gocke CD; Bahceci E; Hill J; Liu C; Xie Z; Carson AR; McClain V; Stenzel TT; Miller JE
Blood Adv; 2018 Apr; 2(8):825-831. PubMed ID: 29643105
[TBL] [Abstract][Full Text] [Related]
19. Revealing very small FLT3 ITD mutated clones by ultra-deep sequencing analysis has important clinical implications in AML patients.
Zuffa E; Franchini E; Papayannidis C; Baldazzi C; Simonetti G; Testoni N; Abbenante MC; Paolini S; Sartor C; Parisi S; Marconi G; Cattina F; Bochicchio MT; Venturi C; Ottaviani E; Cavo M; Martinelli G
Oncotarget; 2015 Oct; 6(31):31284-94. PubMed ID: 26384303
[TBL] [Abstract][Full Text] [Related]
20. FMS-like tyrosine kinase 3 internal tandem duplication and the patterns of its gene sequence in 207 Chinese patients with de novo acute myeloid leukemia.
Zhong L; Jia YQ; Meng WT; Ni X
Arch Pathol Lab Med; 2012 Jan; 136(1):84-9. PubMed ID: 22208491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
